−0.015 HKD
−6.39 M HKD
27.21 M HKD
155.15 M
About HUAKANG BIOMEDICAL HLDGS CO LTD
Sector
Industry
CEO
Chun Guang Zhang
Website
Headquarters
Kowloon
Founded
1992
FIGI
BBG00MPW9BD5
Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The firm engages in the manufacture and sale of in-vitro diagnostic (IVD) reagents in China. Its product portfolio of IVD reagents consists of male fertility IVD reagents, parasite antibody detection reagents and an EBV antibody detection reagent. The company was founded on August 3, 2017 and is headquartered in Kowloon, Hong Kong.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 8622 is 0.182 HKD — it has decreased by −0.55% in the past 24 hours. Watch HUAKANG BIOMEDICAL HLDGS CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange HUAKANG BIOMEDICAL HLDGS CO LTD stocks are traded under the ticker 8622.
8622 stock has risen by 30.94% compared to the previous week, the month change is a 8.33% rise, over the last year HUAKANG BIOMEDICAL HLDGS CO LTD has showed a 85.71% increase.
8622 reached its all-time high on Dec 13, 2018 with the price of 0.540 HKD, and its all-time low was 0.080 HKD and was reached on Jun 5, 2024. View more price dynamics on 8622 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
8622 stock is 3.37% volatile and has beta coefficient of 0.74. Track HUAKANG BIOMEDICAL HLDGS CO LTD stock price on the chart and check out the list of the most volatile stocks — is HUAKANG BIOMEDICAL HLDGS CO LTD there?
Today HUAKANG BIOMEDICAL HLDGS CO LTD has the market capitalization of 91.09 M, it has increased by 44.63% over the last week.
Yes, you can track HUAKANG BIOMEDICAL HLDGS CO LTD financials in yearly and quarterly reports right on TradingView.
8622 net income for the last half-year is −1.93 M HKD, while the previous report showed −4.67 M HKD of net income which accounts for 58.76% change. Track more HUAKANG BIOMEDICAL HLDGS CO LTD financial stats to get the full picture.
No, 8622 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 96.00 employees. See our rating of the largest employees — is HUAKANG BIOMEDICAL HLDGS CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HUAKANG BIOMEDICAL HLDGS CO LTD EBITDA is −3.77 M HKD, and current EBITDA margin is −14.32%. See more stats in HUAKANG BIOMEDICAL HLDGS CO LTD financial statements.
Like other stocks, 8622 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HUAKANG BIOMEDICAL HLDGS CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HUAKANG BIOMEDICAL HLDGS CO LTD technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HUAKANG BIOMEDICAL HLDGS CO LTD stock shows the buy signal. See more of HUAKANG BIOMEDICAL HLDGS CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.